EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Modulating lipid metabolism improves tumor immunotherapy

Yu Ping, Qiuqing Fan, Yi Zhang

Journal for ImmunoTherapy of Cancer · 2025-02 · 13 (2) · e010824

DOI: 10.1136/jitc-2024-010824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 04.02.2025. Verfasst von Yu Ping und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Immunotherapy, Lipid Metabolism, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has progressed significantly in cancer treatment; however, several factors influence its outcomes. Abnormal lipid metabolism, which is frequently observed in cancers, promotes tumor proliferation, invasion, and metastasis. Li et al from the Medical Oncology Department of Chongqing University Cancer Hospital constructed a lipid metabolism scoring system and reported that MK1775 inhibited fatty acid oxidation in tumor-associated macrophages and enhanced T-cell infiltration, further enhancing the efficacy of immunotherapy. This study demonstrated the critical role of lipid metabolism scoring system and lipid metabolism in immunotherapy. Currently, the metabolism of lipids, such as fatty acids, phospholipids, and cholesterol, has been reported to affect the tumor microenvironment by regulating immune cells, including T cells, natural killer cells, and macrophages. These metabolic changes can impair the efficacy of immunotherapy, resulting in tumor progression. Consequently, lipid metabolism emerges as an important immune regulator for improving immunotherapeutic outcomes and provides a novel and powerful strategy for tumor combination therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyLipid MetabolismNeoplasmsAnimalsHumansTumor Microenvironment

Stichwörter der Autor:innen

Immunotherapy

Autor:innen und Institutionen

  • Biotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Biotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China yizhang@zzu.edu.cn.
  • State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou, Henan, China.
  • School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, China.
  • Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.
  • School of Public Health, Zhengzhou University, Zhengzhou, Henan, China.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Ping, Y., Fan, Q., & Zhang, Y. (2025). Modulating lipid metabolism improves tumor immunotherapy. Journal for ImmunoTherapy of Cancer, 13(2), e010824. https://doi.org/10.1136/jitc-2024-010824

Vancouver

Ping Y, Fan Q, Zhang Y. Modulating lipid metabolism improves tumor immunotherapy. Journal for ImmunoTherapy of Cancer. 2025;13(2):e010824. doi:10.1136/jitc-2024-010824

BibTeX
@article{Ping2025,
  author = {Ping, Yu and Fan, Qiuqing and Zhang, Yi},
  title = {Modulating lipid metabolism improves tumor immunotherapy},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  volume = {13},
  number = {2},
  pages = {e010824},
  doi = {10.1136/jitc-2024-010824}
}
Kostenlos starten →